Crystalline forms of 1-benzoyl-4-[2-[4methoxy-7-(3-methyl-1H-1,2,4-triazol-1yl)-1-[(phosphonooxy)methyl]-1Hpyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine

Details for Australian Patent Application No. 2006326432 (hide)

Owner Bristol-Myers Squibb Company

Inventors Gao, Qi; Chen, Chung-Pin H.; Levons, Jaquan Kalani; Digiugno, Dawn; Yang, Bing-Shiou; Gu, Chong-Hui

Agent A J Park

Pub. Number AU-B-2006326432

PCT Pub. Number WO2007/070589

Priority 60/750,247 14.12.05 US

Filing date 13 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 12 July 2012

International Classifications

C07F 9/09 Compounds containing elements of the 5th Group of the Periodic System

A61K 31/437

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/070589 Priority application(s): WO2007/070589

12 July 2012 Application Accepted

  Published as AU-B-2006326432

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326436-Method and system for trading financial instruments

2006326430-Mixing of chemicals into a thin stock pipe